Company
United StatesPublic company, OTC: BCLIBrainStorm Cell Therapeutics, Inc (OTC: BCLI), Hackensack, NJ – FDA Inspections
Inspection records and compliance data for BrainStorm Cell Therapeutics, Inc in Hackensack, New Jersey. 1 FDA inspection on record, last inspected November 05, 2019. Publicly traded as OTC: BCLI.
Company Profile
This profile covers BrainStorm Cell Therapeutics, Inc based in Hackensack, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected November 5, 2019.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 5, 2019 | NAI | Biologics · Bioresearch Monitoring | 1110774 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Holy Name Hospital IRB
New Jersey Organ & Tissue Sharing Network, Inc.
CSL Plasma Inc.
North Jersey Fertility Associates LLC
American National Red Cross (The)
The Valley Hospital Microbiology Laboratory
ABO Holdings Inc
BioLife Plasma Services LP
Bergen Comm Reg Blood Center
Cell Therapies Manufacturing Facility Hackensack University Medical Center
Company Information
Name
BrainStorm Cell Therapeutics, Inc
Stock ticker
BCLI
Exchange
OTC
Price as of
November 6, 2026
FEI Number
3015810303
Address
3 University Plaza Dr Ste 320, Hackensack, New Jersey 07601, United States
Country
United States
ID: e72836b9-8e30-4e59-8b92-415cc76f6a4c